Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia

Schizophrenia Research

Volumn 109, Issue 1-3, 2009, Pages 159-166

  Beasley, Clare L ^a   Dwork, Andrew J ^b,c   Rosoklija, Gorazd ^b,c,d   Mann, J John ^b,c   Mancevski, Branislav ^b,c   Jakovski, Zlatko ^d   Davceva, Natasa ^d   Tait, Andrew R ^a   Straus, Suzana K ^a   Honer, William G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Columbia University ^*  (United States)

^d SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

Author keywords

Axon; Internal capsule; Lactate; Metabolite; Myelin

Indexed keywords

BRAIN PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; NEUROFILAMENT PROTEIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; METABOLIC DISORDER; PRIORITY JOURNAL; SCHIZOPHRENIA; THALAMUS; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; ALANINE; ANISOTROPY; AUTOPSY; BRAIN; CORPUS STRIATUM; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FRONTAL LOBE; FUNCTIONAL LATERALITY; HUMANS; INTERNAL CAPSULE; LACTIC ACID; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELIN BASIC PROTEINS; NEURAL PATHWAYS; SCHIZOPHRENIA; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; THALAMUS;

EID: 62649113836     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.01.017     Document Type: Article

References (52)

1. Alexander G.E., DeLong M.R., and Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9 (1986) 357-381
2. Andreasen N.C., Flashman L., Flaum M., Arndt S., Swayze II V., O'Leary D.S., et al. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 272 (1994) 1763-1739
3. Axer H., and Keyserlingk D.G. Mapping of fiber orientation in human internal capsule by means of polarized light and confocal scanning laser microscopy. J. Neurosci. Methods 94 (2000) 165-175
4. Axer H., Lippitz B.E., and Keyserlingk D.G. Morphological asymmetry in anterior limb of human internal capsule revealed by confocal laser and polarized light microscopy. Psychiatry Res. 91 (1999) 141-154
5. Beasley C.L., Honer W.G., Bergmann K., Falkai P., Lütjohann D., and Bayer T.A. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord. 7 (2005) 449-455
6. Buchsbaum M.S., Schoenknecht P., Torosjan Y., Newmark R., Chu K.W., Mitelman S., et al. Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia. Ann. Gen. Psychiatry 5 (2006) 19
7. Buchsbaum M.S., Buchsbaum B.R., Hazlett E.A., Haznedar M.M., Newmark R., Tang C.Y., and Hof P.R. Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am. J. Psychiatry 164 (2007) 1072-1081
8. Chakos M.H., Lieberman J.A., Bilder R.M., Borenstein M., Lerner G., Bogerts B., et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am. J. Psychiatry 151 (1994) 1430-1436
9. Chudasama Y., and Robbins T.W. Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol. Psychiatry 73 (2006) 19-38
10. Clark L., Cools R., and Robbins T.W. The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn. 55 (2004) 41-53
11. Cohen J. Statistical Power Analysis for the Behavioral Sciences (1988), Lawrence Erlbaum Associates, Hillsdale, New Jersey
12. Dessi F., Colle M.-A., Hauw J.-J., and Duyckaerts C. Accumulation of SNAP-25 immunoreactive material in axons of Alzheimer's disease. NeuroReport 8 (1997) 3685-3689
13. Dracheva S., Davis K.L., Chin B., Woo D.A., Schmeidler J., and Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol. Dis. 21 (2006) 531-540
14. Falkai P., Honer W.G., David S., Bogerts B., and Majtenyi C. No evidence for astrogliosis in brains of schizophrenic patients. Neuropathol. Appl. Neurobiol. 25 (1999) 48-53
15. Flynn S.W., Lang D.J., Mackay A.L., Goghari V.M., Vavasour I.M., Whittall K.P., et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol. Psychiatry 8 (2003) 811-820
16. Giasson B.I., and Mushynski W.E. Aberrant stress-induced phosphorylation of perikaryal neurofilaments. J. Biol. Chem. 271 (1996) 30404-30409
17. Govindaraju V., Young K., and Maudsley A.A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 13 (2000) 129-153
18. Halim N.D., Lipska B.K., Hyde T.M., Deep-Soboslay A., Saylor E.M., Herman M.M., et al. Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds. J. Neurosci. Methods 169 (2008) 208-213
19. Harrison P.J. The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain 12 (1999) 593-624
20. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68
21. Highley J.R., Esiri M.M., McDonald B., Roberts H.C., Walker M.A., and Crow T.J. The size and fiber composition of the anterior commissure with respect to gender and schizophrenia. Biol. Psychiatry 45 (1999) 1120-1127
22. Highley J.R., Esiri M.M., McDonald B., Cortina-Borja M., Herron B.M., and Crow T.J. The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain 122 (1999) 99-110
23. Hof P.R., Haroutunian V., Friedrich V.L., Byne W., Buitron C., Perl D.P., and Davis K.L. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry 53 (2003) 1075-1085
24. Holmes E., Tsang T.M., Huang J.T., Leweke F.M., Koethe D., Gerth C.W., et al. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 3 (2006) e327
25. Honer W.G., Falkai P., Chen C., Arango V., Mann J.J., and Dwork A.J. Synaptic and plasticity associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 91 (1999) 1247-1255
26. Honer W.G., Falkai P., Bayer T.A., Xie J., Hu L., Li H.-Y., et al. Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb. Cortex 12 (2002) 349-356
27. Hulshoff Pol H.E., Schnack H.G., Mandl R.C., Cahn W., Collins D.L., Evans A.C., and Kahn R.S. Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage 21 (2004) 27-35
28. Kemether E.M., Buchsbaum M.S., Byne W., Hazlett E.A., Haznedar M., Brickman A.M., et al. Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch. Gen. Psychiatry 60 (2003) 983-991
29. Kubicki M., Park H., Westin C.F., Nestor P.G., Mulkern R.V., Maier S.E., et al. DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. NeuroImage 26 (2005) 1109-1118
30. Kuperberg G.R., Broome M.R., McGuire P.K., David A.S., Eddy M., Ozawa F., et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch. Gen. Psychiatry 60 (2003) 878-888
31. Lang D.J., Kopala L.C., Vandorpe R.A., Rui Q., Smith G.N., Goghari V.M., et al. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. Am. J. Psychiatry 161 (2004) 1829-1836
32. Lang D.J., Khorram B., Goghari V.M., Kopala L.C., Vandorpe R.A., Rui Q., et al. Reduced anterior internal capsule and thalamic volumes in first-episode psychosis. Schizophr. Res. 87 (2006) 89-99
33. Lim K.O., Adalsteinsson E., Spielman D., Sullivan E.V., Rosenbloom M.J., and Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch. Gen. Psychiatry 55 (1998) 346-352
34. Marner L., and Pakkenberg B. Total length of nerve fibers in prefrontal and global white matter of chronic schizophrenics. J. Psychiatr. Res. 37 (2003) 539-547
35. Massiot D., Fayon F., Capron M., King I., Le Calvé S., Alonso B., et al. Modelling one- and two-dimensional solid state NMR spectra. Magn. Reson. Chem. 40 (2002) 70-76
36. McCullumsmith R.E., Gupta D., Beneyto M., Kreger E., Haroutunian V., Davis K.L., and Meador-Woodruff J.H. Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr. Res. 90 (2007) 15-27
37. McIntosh A.M., Job D.E., Moorhead T.W., Harrison L.K., Lawrie S.M., and Johnstone E.C. White matter density in patients with schizophrenia, bipolar disorder and their unaffected relatives. Biol. Psychiatry 58 (2005) 254-257
38. Melo T.M., Nehlig A., and Sonnewald U. Neuronal-glial interactions in rats fed a ketogenic diet. Neurochem. Int. 48 (2006) 498-507
39. Mitelman S.A., Torosjan Y., Newmark R.E., Schneiderman J.S., Chu K.W., Brickman A.M., et al. Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: a diffusion tensor imaging survey. Schizophr. Res. 92 (2007) 211-224
40. Mitkus S.N., Hyde T.M., Vakkalanka R., Kolachana B., Weinberger D.R., Kleinman J.E., and Lipska B.K. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophr. Res. 98 (2008) 129-138
41. Morland C., Henjum S., Iversen E.G., Skrede K.K., and Hassel B. Evidence for a higher glycolytic than oxidative metabolic activity in white matter of brain. Neurochem. Int. 50 (2007) 703-709
42. Narr K.L., Bilder R.M., Toga A.W., Woods R.P., Rex D.E., Szeszko P.R., et al. Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb. Cortex 15 (2005) 708-719
43. Nicholas A.P., Sambandam T., Echols J.D., and Tourtellotte W.W. Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. J. Comp. Neurol. 473 (2004) 128-136
44. Omori M., Pearce J., Komoroski R.A., Griffin S.T., Mrak R.E., Husain M.M., and Karson C.N. In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia. Biol. Psychiatry 42 (1997) 359-366
45. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T.-J., Griffin J.L., et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 9 (2004) 684-697
46. Robbins T.W. The case of frontostriatal dysfunction in schizophrenia. Schizophr. Bull. 16 (1990) 391-402
47. Robbins T.W. Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Phil. Trans. R. Soc. B. 362 (2007) 917-932
48. Shimizu M., Fujiwara H., Hirao K., Namiki C., Fukuyama H., Hayashi T., and Murai T. Structural abnormalities of the adhesio interthalamica and mediodorsal nuclei of the thalamus in schizophrenia. Schizophr. Res. 101 (2008) 331-338
49. Tekin S., and Cummings J.L. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J. Psychosom. Res. 53 (2002) 647-654
50. Tekkok S.B., Brown A.M., Westenbroek R., Pellerin L., and Ransom B.R. Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J. Neurosci. Res. 81 (2005) 644-652
51. Waagepetersen H.S., Sonnewald U., Larsson O.M., and Schousboe A. A possible role of alanine for ammonia transfer between astrocytes and glutamatergic neurons. J. Neurochem. 75 (2000) 471-479
52. Zhou S.Y., Suzuki M., Hagino H., Takahashi T., Kawasaki Y., Nohara S., et al. Decreased volume and increased asymmetry of the anterior limb of the internal capsule in patients with schizophrenia. Biol. Psychiatry 54 (2003) 427-436